CD4 and breast angiosarcoma: Experimental and clinical studies have proven that CD4+ T cells are implicated in the pathogenesis of BA, resulting in an augmentation of CD4+ T helper 1 (Th1) cells [5] and a depletion of T regulatory (Treg) cells [6].